Oxford BioDynamics (LON:OBD) Reaches New 52-Week Low – Time to Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price hit a new 52-week low during trading on Friday . The company traded as low as GBX 0.17 and last traded at GBX 0.18, with a volume of 11903665 shares traded. The stock had previously closed at GBX 0.20.

Oxford BioDynamics Price Performance

The stock has a market cap of £7.72 million, a P/E ratio of -0.23 and a beta of 0.42. The business has a 50 day simple moving average of GBX 0.22 and a 200-day simple moving average of GBX 0.26. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.